Sutro Biopharma (SUTRO) Shares Up 8% Following 7.9 Million Share Pricing Announcement

Sutro Biopharma (NASDAQ: SUTRO) shares surged 8% in early trading on February 10, 2026, following the announcement of the pricing for 7.9 million shares in its initial public offering. The offering closed at $18.50 per share, raising a total of $147.65 million. The company plans to use the proceeds to support ongoing clinical trials and expand its operations. The stock closed at $43.25 on the NASDAQ, reflecting continued interest from investors following the IPO pricing.